NOT-AI-03-040: BIODEFENSE AND EMERGING INFECTIOUS DISEASES RESEARCH OPPORTUNITIES

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

BIODEFENSE AND EMERGING INFECTIOUS DISEASES RESEARCH OPPORTUNITIES - CORRECTION 
TO PA-03-080

RELEASE DATE:  May 27, 2003

NOTICE:  NOT-AI-03-040

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov/default.htm)

PURPOSE

The research plan for R21 grant applications is limited to 15 pages, not 10 
pages as stated in PA-03-080. Corrected supplemental instructions for R21 
applications follow.

CORRECTED SUPPLEMENTAL INSTRUCTIONS FOR R21 APPLICATIONS: 

To apply, please follow NIH guidelines for submission of an R21 application 
(http://grants.nih.gov/grants/guide/pa-files/PA-03-107.html) as 
listed below: 

1) The description (abstract) must include a brief explanation of the proposed 
activity, and how it is consistent with the exploratory/development nature of 
the R21 mechanism as described in this notice. 

2) Although preliminary data are neither expected nor required for an R21 
application, they may be included. 

3) Sections a-d of the Research Plan may not exceed 15 pages, including tables 
and figures. 

4) Appendix materials should be limited, as is consistent with the exploratory 
nature of the R21 mechanism, and should not be used to circumvent the page 
limit for the research plan. Copies of appendix material will only be provided 
to the primary reviewers of the application and will not be reproduced for 
wider distribution. The following materials may be included in the appendix: 

o Up to five publications, including manuscripts (submitted or accepted for 
publication), abstracts, patents, or other printed materials directly relevant 
to the project. These may be stapled as sets. 

o Surveys, questionnaires, data collection instruments, and clinical protocols. 
These may be stapled as sets. 

o Original glossy photographs or color images of gels, micrographs, etc., 
provided that a photocopy (may be reduced in size) is also included within the 
15-page limit of items a-d of the research plan. 

Include five collated sets of all appendix material, in the same package with 
the application, following all copies of the application. Identify each item 
with the name of the principal investigator. 

SENDING AN R21 APPLICATION TO THE NIH: Submit a signed, typewritten original of 
the application, including the checklist, and five signed photocopies and all 
appendices in one package to:

Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD  20892-7710
Bethesda, MD  20817 (for express/courier service)

INQUIRIES

We encourage your inquiries concerning this notice and welcome the opportunity 
to answer questions from potential applicants.  

Direct inquiries to:

Sam Perdue, Ph.D.
Program Officer, Rickettsial and Related Diseases
National Institute of Allergy and Infectious Disease
Room 4115; 6610 Rockledge Dr.
Bethesda, MD 20817
Telephone: 301/402-5083
Fax: 301/402-2508
Email: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices